Singapore, April 26 -- The wait is finally over and by popular demand, the leading ADC industry touchpoint is heading to Asia again this Summer!

With a storm of collaborations and novel innovations happening, all eyes are turning towards the APAC region for the next best thing when it comes to antibody-drug conjugate development. The 3rd World ADC Asia (June 25-27, 2024 |Incheon, South Korea) is back to unite the growing community of Asian-based drug developers.

The 3-day agenda has been designed to allow insightful discussions into your most pressing challenges, novel payloads, identifying unique targets, stable linker chemistries, working through manufacturing and regulatory hurdles, and more to boost ADC development and innovation. ...